Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Regeneron Pharmaceuticals, Inc. (NQ: REGN)
266.97 USD  +2.31 (+0.87%)
Official Closing Price  /  Updated: 4:00 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Regeneron Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Regeneron's EYLEA Submitted for EU Marketing Authorization for Treatment of Macular Edema
December 06, 2012
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) and Bayer HealthCare today announced that Bayer HealthCare (OTC: BAYRY ) has submitted an application for marketing authorization in Europe for EYLEA... Read More
category Management , Benzinga , REGN , and 8 more.
from Latest Articles from Benzinga.com
5 Analyst Darlings to Buy and 5 to Sell Right Now
December 04, 2012
 Read More
category NYSE:LPL , Stock Picks , NASDAQ:REGN , and 3 more.
from InvestorPlace - Latest Headlines
Notable ETF Inflow Detected - IJH, REGN, HFC, AME
December 03, 2012
Symbols mentioned in this story: IJH, REGN, HFC, AME Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Uptrend Call Working As Regeneron Pharmaceuticals Stock Rises 17.3% (REGN)
December 03, 2012
from Comtex SmarTrend® News Briefs
5 Stocks With Superb Sales Growth — AGM ESGR SWSH REGN APSA
December 03, 2012
 Read More
category NYSE:AGM , NASDAQ:ESGR , Stocks to Buy , and 3 more.
from InvestorPlace - Latest Headlines
Celgene, Regeneron Pharmaceutical Lead Biomed Group
November 30, 2012
What a difference a month makes. The biomed industry group started November with a top-10 ranking among the 197 industries tracked by IBD. By the end of the first full week of the month, a week... Read More
category IBD Industry Themes
from Investor's Business Daily - Investing RSS
Regeneron Pharmaceuticals Among Healthcare's Biggest Movers on November 30, 2012
November 30, 2012
This morning's trading has marked a bad day for the market so far. The Nasdaq has decreased 0.4%; the S&P 500 has slipped 0.2%; and the Dow is trading down 0.2%. The healthcare sector is the category... Read More
from Investopedia Advisor Commentary
Regeneron (REGN) Selected as Biotech Company of the Year by Scrip Intelligence
November 29, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7912132 for the full story. Read More
from StreetInsider.com News Articles
Express Scripts and More Big Movers in Healthcare on November 29, 2012
November 29, 2012
On a good day for the market, the Nasdaq is trading up 0.5%, the S&P 500 has moved up 0.5% and the Dow has risen 0.4%. The healthcare sector is the category of stocks relating to medical and healthcar... Read More
from Investopedia Advisor Commentary
Regeneron's EYLEA Injection Approved for Treatment of Wet Age-Related Macular Degeneration by EC
November 27, 2012
Regeneron Pharmaceuticals (NASDAQ: REGN ) today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of patients with neovascular (wet)... Read More
category Contracts , Management , Benzinga , and 5 more.
from Latest Articles from Benzinga.com
5 Stocks With Superb Sales Growth — AGM ESGR SWSH REGN APSA
November 26, 2012
 Read More
category NYSE:AGM , NASDAQ:ESGR , Stocks to Buy , and 3 more.
from InvestorPlace - Latest Headlines
Baxter and More Big Movers in Healthcare on November 26, 2012
November 26, 2012
The market is having a bad day so far. The Nasdaq has decreased 0.4%; the S&P 500 has slipped 0.7%; and the Dow is trading down 0.8%. The healthcare sector is the category of stocks relating to medica... Read More
from Investopedia Advisor Commentary
Regeneron, Valspar, FleetCor Hit Highs In Fast Trade
November 20, 2012
Two stocks with high ratings broke to new highs in strong volume Tuesday, and a third continued to show no signs of pulling back despite the market correction. Drugmaker Regeneron Pharmaceuticals... Read More
category New Highs
from Investor's Business Daily - Investing RSS
Regeneron (REGN) Pops Higher; Deutsche Sees AAO/ASRS as Positive for Branded Drugs
November 20, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7894221 for the full story. Read More
from StreetInsider.com News Articles
Regeneron Pharmaceuticals and More Big Movers in Healthcare on November 20, 2012
November 20, 2012
This morning, the market has been relatively quiet. The Nasdaq remains relatively unchanged; the S&P 500 has been relatively flat; and the Dow has remained steady. The healthcare sector is the categor... Read More
from Investopedia Advisor Commentary
Regeneron Pharmaceuticals and Other Nasdaq Stocks Making Big Moves on November 20, 2012
November 20, 2012
This morning, there has been little change in the market. The Nasdaq, S&P 500 and Dow have barely moved. The Nasdaq Composite Index is a capitalization-weighted index, with each company weighted in pr... Read More
from Investopedia Advisor Commentary
5 Stocks With Strong Sales Growth — AGM SWSH REGN APSA AGX
November 19, 2012
 Read More
category NYSE:AGM , AMEX:AGX , Stocks to Buy , and 3 more.
from InvestorPlace - Latest Headlines
Biotech Movers: Regeneron Pops, 3 Flop
November 19, 2012
 Read More
category NASDAQ:DVAX , NASDAQ:REGN , NASDAQ:CLVS , and 3 more.
from InvestorPlace - Latest Headlines
REIT speculation boosts senior home shares
November 16, 2012
Speculation that plans to spin off a casino operator’s real-estate assets into a REIT is fueling a boost in Brookdale Senior Living shares. Read More
category REGN , FIG , Financial Services , and 16 more.
from MarketWatch
5 Stocks With Superb Analyst Earnings Revisions — OSTK STC MITT PPC REGN
November 16, 2012
 Read More
category NYSE:STC , NASDAQ:OSTK , NYSE:MITT , and 3 more.
from InvestorPlace - Latest Headlines
Regeneron Pharmaceuticals Among Healthcare's Biggest Movers on November 16, 2012
November 16, 2012
The market is currently down, with the Nasdaq slipping 1%, the S&P 500 declining 0.6% and the Dow falling 0.8%. The healthcare sector is the category of stocks relating to medical and healthcare goods... Read More
from Investopedia Advisor Commentary
5 Stocks With Superb Analyst Earnings Revisions — OSTK STC MITT PPC REGN
November 16, 2012
 Read More
category NYSE:STC , NASDAQ:OSTK , NYSE:MITT , and 3 more.
from InvestorPlace - Latest Headlines
WuXi, Regeneron In Buying Range Despite Market's Woes
November 15, 2012
Medical stocks WuXi PharmaTech (WX) and Regeneron Pharmaceuticals (REGN) are in buying range after holding up relatively well amid the market's post-election sell-off. China-based WuXi -- an... Read More
category Stocks In The News
from Investor's Business Daily - Investing RSS
Regeneron Pharmaceuticals Crosses Below its 10-day MA (REGN)
November 15, 2012
from Comtex SmarTrend® News Briefs
Regeneron Pharmaceuticals Among Healthcare's Biggest Movers on November 15, 2012
November 15, 2012
The market is currently down, with the Nasdaq falling 0.4%, the S&P 500 decreasing 0.3% and the Dow declining 0.3%. The healthcare sector is the category of stocks relating to medical and healthcare g... Read More
from Investopedia Advisor Commentary
Credit Suisse Starts Regeneron Pharma (REGN) at Outperform
November 13, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7867669 for the full story. Read More
from StreetInsider.com News Articles
5 Stocks With Strong Sales Growth — CRIS SWSH REGN APSA AGX
November 12, 2012
 Read More
category AMEX:AGX , Stocks to Buy , NASDAQ:SWSH , and 3 more.
from InvestorPlace - Latest Headlines
5 Stocks With Great Analyst Earnings Revisions — OSTK STC MITT PPC REGN
November 09, 2012
 Read More
category NYSE:STC , NASDAQ:OSTK , NYSE:MITT , and 3 more.
from InvestorPlace - Latest Headlines
Novartis Touts Pipeline of Blockbuster Drugs
November 08, 2012
 Read More
category NYSE:NVS , NASDAQ:BIIB , NASDAQ:REGN , and 1 more.
from InvestorPlace - Latest Headlines
RBC Thinks Amgen's (AMGN) AMG145 Has 'Compelling' Safety Profile Profile; Sees $10B Market Opportunity
November 07, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7852447 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here